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As part of screening aimed at the selection of novel antimycotic compounds of vegetable origin, leaf extracts
of Camellia sinensis L., Cupressus sempervirens L. and Pistacia lentiscus L. and the seed extract of Glycine
soja Sieb. et Zucc. were tested against yeast and yeast-like species implicated in human mycoses. Of the
extracts only those of C. sinensis (obtained from a commercial preparation of green tea) exhibited broad
activity towards Candida glabrata, Clavispora lusitatiae, Cryptococcus laurentii, Filobasidiella neoformans,
Issatchenkia orientalis, Saccharomyces cerevisiae and Prototheca wickerhamii strains. MICs ranging from
300 to 4800 µg extract/mL (corresponding to 130–2010 µg/mL total polyphenols) were observed. Concentra-
tions of the C. sinensis extract over 25 000 µg/mL caused a rapid decrease of viable cells of Fil. neoformans
and its activity was dose-dependent. Tests carried out using the pure polyphenols present in C. sinensis extract
composition, showed that only epicatechin-3-O-gallate (ECG) and epigallocatechin-3-O-gallate (EGCG) pos-
sess antimycotic activity. Copyright © 2005 John Wiley & Sons, Ltd.
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INTRODUCTION
The antimicrobial properties of drugs from medicinal
and other edible plants have been recognized since
antiquity (Cowan, 1999). Notwithstanding the wide
literature concerning the beneficial effects of plant
polyphenols in human health (Cowan, 1999; Krauze-
Baranowska et al., 1999; Lin et al., 1999; Cassidy et al.,
2000; Wang, 2000), to our knowledge little information
is available on their antimycotic properties towards yeast
and yeast-like microorganisms, which are implicated
in many human pathologies (Hazen, 1995; Rex et al.,
1995; Warren and Hazen, 1998). In view of the increased
number of fungal infections, especially in immuno-
depressed subjects (Kalowky et al., 1997), and of the
development of resistance towards antifungal agents
(Hazen, 1995; Rex et al., 1995; Warren and Hazen, 1998;
Sanglard and Odds, 2002), there is a considerable
scientific and commercial interest in the discovery of
novel classes of antimycotic compounds.
Plants represent a good source of novel antimicro-
bial molecules (Rusia and Srivastava, 1988; Ayoub, 1989;
Mahajan et al., 1991; Etkin, 1996; Arora and Ohlan,
1997; Chapman et al., 1997; Johns, 1999; Pieroni, 2000;
Buzzini and Pieroni, 2003). Therefore the antimycotic
activity was investigated of an extract of Camellia
sinensis L. leaves and Glycine soja Sieb. et Zucc seeds,
plants of special importance in the oriental diet which
is very rich in polyphenols. In particular, the former is
rich in galloyl-catechins (Riemersma et al., 2001) while
the latter is very rich in isoflavones such as genistein
and daidzein glycosides (Romani et al., 2003). In order
to investigate whether other polyphenol classes may
have an antimycotic activity another edible plant of the
Mediterranean region was selected, Pistacia lentiscus,
which contains galloyl-quinic esters and myricetin glyco-
sides as the main compounds (Romani et al., 2002b).
Moreover, Cupressus sempervirens extract has been
investigated because it is rich in biflavonoids, quercetin
and kaempferol glycosides (Romani et al., 2002a). The
present paper compared the activity of different plant
extracts in order to identify what class of polyphenols
is able to express antimycotic activity towards yeast
and yeast-like microorganisms implicated in many
human pathologies (Hazen, 1995; Rex et al., 1995;
Warren and Hazen, 1998).
MATERIALS AND METHODS
Plant material. The leaves of the mastic tree and
cypress tree were collected from fully developed plants
growing in Tuscany (Italy) at the end of June and
September (mastic tree) and October (cypress tree)
2002. In both cases the leaves were processed as previ-
ously described (Romani et al., 2002a; Romani et al.,
2002b). Soy seeds, collected from plants grown under
natural conditions, were ground and extracted as
previously reported (Romani et al., 2003). Green tea
extract (from Camellia sinensis leaves) was obtained
from Indena S.p.A., Milan, Italy. The extracts were
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stored at −20 °C until use and were stable for at least
12 months.
HPLC/DAD and HPLC/MS analysis. The analysis
was carried out using a HP-1100 liquid chromato-
graph equipped with a DAD detector and a HP 1100
MSD API-electrospray (Agilent-Technologies, Palo
Alto, USA) operating in positive and negative ioniza-
tion mode. Analytical conditions were described
previously (Romani et al., 2003). Identification of
individual polyphenols was carried out on the basis
of their retention times, spectroscopic and spectro-
metric data. Quantification of individual polyphenols
was directly performed by HPLC-DAD by using
four-point regression curves built with the available
standards or isolated compounds. The following
standards were used for the identification and charac-
terization of plant extracts: phenolic acid (ellagic acid,
gallic acid, caffeic acid, chlorogenic acid and cynarin);
secoiridoid (oleuropein); flavones (apigenin, cosmetin,
homoorientin, vitexin, luteolin, luteolin-4′-glucoside);
flavonols (quercetin, quercetagetin, quercetin-3-
arabinoside, quercitrin, isoquercitrin, fisetin, kaempferol,
kaempferol-7-neohesperidoside, myricetin, myricitrin,
rhamnetin, isorhamnetin and robinin); flavanones
(eriodictyol, hesperidin, naringenin, naringenin-7-
glucoside and pinocembrin-7-methylther); isoflavones
(daidzein and genistein); chalcones (phloridzin) and
catechins, epicatechin-3-O-gallate (ECG), epigallo-
catechin (EGC) and epigallocatechin-3-O-gallate
(EGCG). Calibration curves with r 2 ≥ 0.9998 were
considered. The quantification was performed at the
maximum wavelength of UV-Vis absorbance by apply-
ing the correction for molecular weight.
In particular, in G. soja seed extract genistein and
glycitein derivatives were determined at 260 nm using
genistein as a reference compound, while daidzein
derivatives were determined at 305 nm with daidzein
as a reference; in P. lentiscus leaf extract the galloyl-
glycosides and galloyl-quinic acid amounts were calcu-
lated at 280 nm using gallic acid as a reference, while
myricetin and quercetin glycosides were calibrated
at 350 nm with myricitrin and rutin, respectively, as a
reference; in C. sempervirens leaf extract the flavonol
content was determined at 350 nm employing the
authentic standard quercitrin and kaempferol, in the
same way biflavonoids and methylbiflavonoids were
quantified with the authentic standard hinokiflavone and
amentoflavone; finally, the commercial extract of green
tea was calibrated at 280 nm using the authentic stand-
ards of catechin and gallo-catechins, while its flavonol
content was calculated at 350 nm using rutin as a refer-
ence compound.
Microorganisms. Twenty-four yeast (belonging to
13 species of nine genera) and three yeast-like
(Prototheca spp.) strains of different origin (conserved
in the DBVPG Collection of Industrial Yeasts at
the Dipartimento di Biologia Vegetale e Biotecno-
logie Agroambientali, University of Perugia, Italy,
www.agr.unipg.it/dbvpg) (Buzzini and Martini, 2000)
were used as target microorganisms (Table 1). Several
of these, although belonging to species commonly
regarded as species of agro-industrial interest, have
gained the status of emerging pathogens in recent years
because they are implicated in opportunistic infections
(Hazen, 1995; Rex et al., 1995; Warren and Hazen, 1998).
Working cultures were maintained on YEPG (g/L: yeast
Table 1. Salient information on yeasts and yeast-like microorganisms used in the present study
Species Strain Status Source of isolation Locality of isolation
Candida albicans DBVPG 6133 T Skin mycosis Uruguay
Candida albicans DBVPG 6157 NT of Candida stellatoidea Unknown Unknown
Candida glabrata DBVPG 7212 Unknown Unknown
Candida glabrata DBVPG 3828 T Faeces Unknown
Pichia guilliermondii DBVPG 6140 T of Candida guilliermondii Sputum Unknown
Candida parapsilosis DBVPG 6150 T Ex case of sprue Puerto Rico
Candida tropicalis DBVPG 3982 T Bronchitic patient Unknown
Candida zeylanoides DBVPG 6163 NT Blastomycotic macroglossia Unknown
Clavispora lusitaniae DBVPG 6142 T of Candida lusitaniae Caecum of pig Portugal
Clavispora lusitaniae DBVPG 6148 Sputum Norway
Issatchenkia orientalis DBVPG 6782 Fruit juice Unknown
Kluyveromyces marxianus DBVPG 6141 T of Candida kefir Kefyr grain The Netherlands
Saccharomyces cerevisiae DBVPG 6173 T Brewer’s top yeast The Netherlands
Saccharomyces cerevisiae DBVPG 6497 Unknown Unknown
Saccharomyces cerevisiae DBVPG 6500 Unknown Unknown
Yarrowia lipolitica DBVPG 6053 T Maize-processing plant USA
Cryptococcus laurentii DBVPG 3883 Phlegm of a tuberculosis patient Unknown
Cryptococcus laurentii DBVPG 4272 Human oral cavity Italy
Cryptococcus laurentii DBVPG 6265 T Palm wine Congo
Filobasidiella neoformans DBVPG 3428 Unknown Unknown
Filobasidiella neoformans DBVPG 6010 T of Cryptococcus neoformans Fermenting fruit juice Unknown
Filobasidiella neoformans DBVPG 6225 Spinal fluid USA
Filobasidiella neoformans DBVPG 6981 Cerebrospinal fluid USA
Filobasidiella neoformans DBVPG 6982 Droppings of cuckoo Thailand
Prototheca wickerhamii DBVPG 8879 Unknown Unknown
Prototheca zopfii DBVPG 8880 Unknown Unknown
Prototheca zopfii DBVPG 8830 Milk from a mastiytic cow Italy
T, Type strain; NT, Neotype.
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extract 10, peptone 10, glucose 20, agar 15) or potato
dextrose agar (PDA) (Atlas and Parks, 1993) slants at
4 °C until use.
Antimycotic activity test. Antimycotic activity of the
crude extracts was evaluated by using the agar dif-
fusion well bioassay (ADWB) (Buzzini and Martini,
2001) with YEPG or yeast nitrogen base (YNB)
agar (Difco, Detroit, Michigan, USA) + 2% glucose as
substrates.
One mL of 24 h cell suspensions (105 cells/mL corre-
sponding to an A580 = 0.1 – 0.2) of strains were mixed
thoroughly with 19 mL molten medium (45 °C) and
poured into a Petri dish. After the agar had solidified,
six wells (diameter 8 mm) were cut equidistant from
the edge of the inoculated dish. An aliquot (100 µL) of
extract or standard stock solution was placed in each
well. Dishes were checked for the presence of inhibi-
tion zones (halos) every 12 h. In this phase of the work,
antimicrobial activity was assessed by measuring the
diameter of the clear area of inhibition.
Ketoconazole (as control antibiotic) (Calbiochem Inc.,
USA) and standard compounds, as listed above, were
also tested for their antimycotic activity by ADWB. All
tests were performed in triplicate.
Determination of minimal inhibitory concentration
(MIC). MIC determination was carried out in 96-
well microplates (Corning Inc., USA) by a broth
microdilution method in agreement with the NCCLS
recommendations (NCCLS, 1997). The extracts were
diluted in YNB broth + 2% glucose in order to obtain
concentrations ranging from 5000 to 100 µg/mL. Stock
solutions (100 µg/mL) of ketoconazole (as control anti-
biotic) in 10% dimethyl sulphoxide (DMSO) (Carlo
Erba, Italy) was prepared before use and concen-
trations ranging from 100 to 0.1 µg/mL were used.
Assessment of fungicidal activity of C. sinensis extract.
Cells of Fil. neoformans DBVPG 6010, grown for
24 h at 25 °C on YEPG agar slants, were suspended in
sterile distilled water (106 cells/mL). A quantity of 50 µL
of cell suspension was used as the inoculum of 450 µL
of YNB broth + 2% glucose. Aliquots of extract were
added to obtain increasing concentrations: 1250, 2500,
6250, 12 500, 25 000 and 50 000 µg/mL of extract. Over
a period of 32 h, aliquots of cultures were collected at
4 h intervals and viable cells were plated on YEPG
agar dishes. Colonies were counted after 48–72 h. A
control test (extract free) was also included.
RESULTS AND DISCUSSION
C. sinensis extract was particularly rich in galloyl-
derivatives of catechins with epigallocatechin-3-O-
gallate, epigallocatechin and epicatechin being the lead
compounds (Table 2). Indeed in P. lentiscus extract,
the most prominent compounds were galloyl-derivatives
(galloyl quinic acid, galloyl glycosides), gallic acid and
flavonol glycosides (Table 2). G. soja extracts were
very rich in isoflavones such as daidzein and genistein
(Table 2), whereas the flavonoids and biflavonoids
were the major compounds in the leaf extract of C.
sempervirens (Table 2). The polyphenol composition
of extracts was in line with previously reported data
(Romani et al., 2002a; 2002b; 2003).
The extracts from the cypress tree, mastic tree and
soybean did not show any antimycotic activity against
yeast and yeast-like strains (data not shown). Thus,
galloyl quinic acid, galloyl glycosides, gallic acid,
myricetin glycosides present in P. lentiscus, isoflavones
of G. soja and the flavonoids and biflavonoids of C.
sempervirens had no antimycotic activity.
Table 2. Quantitative analysis of polyphenols (expressed as µg/mL) present in the extracts from leaves
of C. sempervirens, C. sinensis and P. lentiscus, and seeds of G. soja
Extract composition (µg/mL)
Compound C. sempervirens C. sinensis G. soja P. lentiscus
Genistein n.d. n.d. 5.3 n.d.
Genistein-glycosides n.d. n.d. 303 n.d.
Daidzein n.d. n.d. 13 n.d.
6 OH-Daidzein n.d. n.d. 2.7 n.d.
Daidzein glycosides n.d. n.d. 490 n.d.
Glycithin glycosides n.d. n.d. 28 n.d.
Caffeic acid derivatives n.d. n.d. 16 n.d.
Gallic acid n.d. 0.9 n.d. 25
Galloyl glycosides n.d. n.d. n.d. 19
Galloyl quinic acid n.d. n.d. n.d. 310
Myricetin glycosides n.d. n.d. n.d. 102
Quercetin glycosides 174 n.d. n.d. 25
Kaemferol glycosides 16 n.d. n.d. n.d.
Flavonols (as equivalent rutin) n.d. 35 n.d. n.d.
Biflavonoids 1460 n.d. n.d. n.d.
Methylbiflavonoids 4 n.d. n.d. n.d.
Epigallocatechin-3-O-gallate (EGCG) n.d. 211 n.d. n.d.
Epigallocatechin (EGC) n.d. 105 n.d. n.d.
Epicatechin (EC) n.d. 27 n.d. n.d.
Epicatechin-3-O-gallate (ECG) n.d. 36 n.d. n.d.
Catechin n.d. 4 n.d. n.d.
n.d., not detected.
ANTIMYCOTIC ACTIVITY OF PLANT EXTRACTS 47
Copyright © 2005 John Wiley & Sons, Ltd. Phytother. Res. 19, 44–49 (2005)
Table 3. Antimycotic activity of the C. sinensis extract and of ketoconazole towards yeast and yeast-like strains
Diameter of inhibition area (mm)
Camellia sinensis Ketoconazole
extract (2500 µg/mL) (100 µg/mL)
Species Strain A B A B
Candida albicans DBVPG 6133 56.2 60.8
Candida albicans DBVPG 6157 51.6 73.6
Candida glabrata DBVPG 7212 17.7 38.9
Candida glabrata DBVPG 3828 17.3 25.5
Pichia guilliermondii DBVPG 6140 54.6 64.5
Candida parapsilosis DBVPG 6150 60.3 65.6
Candida tropicalis DBVPG 3982
Candida zeylanoides DBVPG 6163 49.1 58.8
Clavispora lusitaniae DBVPG 6142 12.9 12.0 54.2 67.7
Clavispora lusitaniae DBVPG 6148 13.2 22.3 56.7 64.6
Issatchenkia orientalis DBVPG 6782 16.5 17.5 29.6 31.1
Kluyveromyces marxianus DBVPG 6141 56.2 72.4
Saccharomyces cerevisiae DBVPG 6173 16.8 23.5
Saccharomyces cerevisiae DBVPG 6497 16.9 16.1
Saccharomyces cerevisiae DBVPG 6500 19.3 26.0
Yarrowia lipolitica DBVPG 6053 35.6 46.0
Cryptococcus laurentii DBVPG 3883 17.8 17.3 39.7 45.2
Cryptococcus laurentii DBVPG 4272 28.1 26.0
Cryptococcus laurentii DBVPG 6265 19.1 18.8 42.6 47.9
Filobasidiella neoformans DBVPG 3428 18.8 22.0 44.8 56.6
Filobasidiella neoformans DBVPG 6010 15.9 27.9 46.7 50.4
Filobasidiella neoformans DBVPG 6225 16.0 17.4 36.8 50.8
Filobasidiella neoformans DBVPG 6981 16.0 26.3 37.4 43.5
Filobasidiella neoformans DBVPG 6982 17.4 28.0 38.4 53.4
Prototheca wickerhamii DBVPG 8879 22.0 23.7
Prototheca zopfii DBVPG 8880
Prototheca zopfii DBVPG 8830
A, test carried out on YNB + 2% glucose agar dishes; B, test carried out on YEPG agar dishes.
Table 4. Minimal inhibitory concentration (MIC) of the C. sinensis extract and of ketoconazole
towards yeasts and yeast-like strains
MIC (µg/mL)
Camellia sinensis
Species Strain Extract Total polyphenols Ketoconazole
Candida glabrata DBVPG 3828 1200 502 r
Clavispora lusitaniae DBVPG 6148 700 293 7.5
Issatchenkia orientalis DBVPG 6782 2400 1006 98.1
Saccharomyces cerevisiae DBVPG 6173 2400 1006 r
Cryptococcus laurentii DBVPG 6265 600 251 48.2
Filobasidiella neoformans DBVPG 6010 4800 2011 48.1
Prototheca wickerhamii DBVPG 8879 300 126 r
r, resistant to concentration of 100 µg/mL.
extract of C. sinensis possesses a broad antimycotic
activity and, more importantly, is still active against
yeast and yeast-like strains resistant to ketoconazole.
As already mentioned, drug resistance is a real prob-
lem in the clinical, setting in agreement with recent
literature reporting the occurrence of yeast strains able
to grow in the presence of azole-derivatives (Marichal
et al., 1997; De Resende and De Resende, 1999;
Bouchara et al., 2000).
At very high concentration (25 000 µg/mL), C. sinensis
extract caused a rapid decrease of viable cells of Fil.
neoformans DBVPG 6010, whereas lower concen-
trations appeared to have an initially fungistatic phase
The growth of Clavispora lusitaniae, Issatchenkia
orientalis, Cryptococcus laurentii and Filobasidiella
neoformans strains was inhibited by C. sinensis ex-
tract and ketoconazole. In addition, some strains of
Prototheca wickerhamii, Saccharomyces cerevisiae, Cr.
laurentii and Candida glabrata, which were resistant to
ketoconazole, were susceptible to C. sinensis extract
while Candida tropicalis and Prototheca zopfii strains
which are resistant to ketoconazole were also resistant
to C. sinensis extract (Table 3).
The MICs of C. sinensis extract ranged from 300 to
4800 µg/mL (corresponding to 130–2010 µg/mL of total
polyphenols) (Table 4). This study shows that the leaf
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Figure 1. Assessment of fungicidal activity of the C. sinensis
extracts towards Fil. neoformans DBVPG 6010. , control; ,
25 000 µg/mL; , 12 500 µg/mL.
Figure 2. Dose-response effect of the C. sinensis extract towards
Fil. neoformans DBVPG 6010.
(24 h), rapidly followed by cell death (Fig. 1), the effect
of the extract being dose-dependent (Fig. 2).
In order to identify the molecules involved in the
antimycotic activity, the pure polyphenols present in
C. sinensis extract composition (Table 2) were tested
by ADWB. Among them only epicatechin-3-O-gallate
(ECG) and epigallocatechin-3-O-gallate (EGCG) were
able to inhibit the growth of Fil. neoformans DBVPG
6010 (data not shown).
Catechins and galloyl-derivatives of catechins are a
well known class of compounds exhibiting a consider-
able antibacterial activity (Nisiyama and Kozaki, 1974;
Ryu, 1982; Cheng-Chun et al., 1999; Johns, 1999; Pieroni,
2000). Chou and Lin (1987) fractionated tea flush
and found that the fraction exhibiting the strongest
antimicrobial activity contained mainly EGC and ECG,
whereas Hara et al. (1995) demonstrated that EGC,
ECG and EGCG inhibit the growth of Clostridium
botulinum. Interestingly, the green tea catechins were
also able to inhibit adenovirus activity (Weber et al.,
2003). On the other hand, the antimycotic activity of
these compounds, to our knowledge, has been very
little investigated (Hirasawa and Takada, 2004). On the
basis of the results of the present investigation, it is
possible to point out that the broad activity of C. sinensis
extract towards yeast and yeast-like strains may be as-
cribed apparently to the presence of ECG and EGCG.
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